TNGX
Tango Therapeutics Inc
NASDAQ: TNGX · HEALTHCARE · BIOTECHNOLOGY
$20.98
-2.96% today
Updated 2026-05-01
Market cap
$3.18B
P/E ratio
—
P/S ratio
51.01x
EPS (TTM)
$-0.87
Dividend yield
—
52W range
$1 – $28
Volume
3.5M
Tango Therapeutics Inc (TNGX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |